Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Plos Pathogens
|
January 21, 2025
Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity
Caio Foulkes, Nikolas Friedrich, Branislav Ivan, et al.
Plos Pathogens
|
July 26, 2008
CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristics
Andreas Schweizer, Peter Rusert, Livia Berlinger, et al.
The Journal of Experimental Medicine
|
March 2, 2011
MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1
Claudia R Ruprecht, Anders Krarup, Lucy Reynell, et al.
Journal of Virology
|
June 16, 2005
Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors
Peter Rusert, Herbert Kuster, Beda Joos, et al.
Journal of Virology
|
March 15, 2013
Conformation-dependent recognition of HIV gp120 by designed ankyrin repeat proteins provides access to novel HIV entry inhibitors
Axel Mann, Nikolas Friedrich, Anders Krarup, et al.
Cell Reports. Medicine
|
August 31, 2024
Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines
Magdalena Schwarzmüller, Cristina Lozano, Merle Schanz, et al.
Plos Pathogens
|
March 7, 2017
Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality
David Beauparlant, Peter Rusert, Carsten Magnus, et al.
Journal of Virology
|
July 5, 2005
Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions
Beda Joos, Alexandra Trkola, Marek Fischer, et al.
Nature Medicine
|
May 10, 2005
Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies
Alexandra Trkola, Herbert Kuster, Peter Rusert, et al.
Gut
|
April 26, 2011
Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection
Anna Haas, Kathrin Zimmermann, Frederik Graw, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Plos Pathogens
|
January 21, 2025
Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity
Caio Foulkes, Nikolas Friedrich, Branislav Ivan, et al.
Plos Pathogens
|
July 26, 2008
CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristics
Andreas Schweizer, Peter Rusert, Livia Berlinger, et al.
The Journal of Experimental Medicine
|
March 2, 2011
MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1
Claudia R Ruprecht, Anders Krarup, Lucy Reynell, et al.
Journal of Virology
|
June 16, 2005
Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors
Peter Rusert, Herbert Kuster, Beda Joos, et al.
Journal of Virology
|
March 15, 2013
Conformation-dependent recognition of HIV gp120 by designed ankyrin repeat proteins provides access to novel HIV entry inhibitors
Axel Mann, Nikolas Friedrich, Anders Krarup, et al.
Cell Reports. Medicine
|
August 31, 2024
Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines
Magdalena Schwarzmüller, Cristina Lozano, Merle Schanz, et al.
Plos Pathogens
|
March 7, 2017
Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality
David Beauparlant, Peter Rusert, Carsten Magnus, et al.
Journal of Virology
|
July 5, 2005
Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions
Beda Joos, Alexandra Trkola, Marek Fischer, et al.
Nature Medicine
|
May 10, 2005
Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies
Alexandra Trkola, Herbert Kuster, Peter Rusert, et al.
Gut
|
April 26, 2011
Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection
Anna Haas, Kathrin Zimmermann, Frederik Graw, et al.
Page
of 5